An opinion piece by a gastroenterologist specialising in obesity treatment is a good reminder that in the real world all medicines have a downside. Patients need to be advised that (like many other medicines) the effects of GLP-1 agonists will not persist upon cessation. If obesity is to be regarded as a chronic medical condition, it may be that we will have to realise that chronic medical management will be necessary for many patients.

Read the article here.